Chemistry:SB-612,111
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Other names | SB-612,111 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C24H29Cl2NO |
Molar mass | 418.40 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
SB-612,111 is an opioid receptor ligand which is a potent and selective antagonist for the nociceptin receptor (ORL-1), several times more potent than the older drug J-113,397.[1] It does not have analgesic effects in its own right, but prevents the development of hyperalgesia,[2] and also shows antidepressant effects in animal studies.[3]
See also
References
- ↑ "Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies". The Journal of Pharmacology and Experimental Therapeutics 321 (3): 961–7. June 2007. doi:10.1124/jpet.106.116764. PMID 17329552.
- ↑ "Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)". The Journal of Pharmacology and Experimental Therapeutics 308 (2): 454–61. February 2004. doi:10.1124/jpet.103.055848. PMID 14593080.
- ↑ "Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vivo studies". The Journal of Pharmacology and Experimental Therapeutics 321 (3): 968–74. June 2007. doi:10.1124/jpet.106.116780. PMID 17329551.
Original source: https://en.wikipedia.org/wiki/SB-612,111.
Read more |